Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

8,310 studies match

clinicaltrialsPublishedShowing 51–100 of 8,310 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05430802	Neoadjuvant Furmonertinib and Cisplatin/Pemetrexed as in EGFR Mutated Stage IIA-IIIB Resectable NSCLC (FORESEE)	active not recruiting	Phase 2	40	Tang-Du HospitalOTHER	1	Sep 25, 2026	clinicaltrials
NCT05488314	A Study of Amivantamab and Capmatinib Combination Therapy in Unresectable Metastatic Non-small Cell Lung Cancer(METalmark)	active not recruiting	Phase 1 / Phase 2	57	Janssen Research & Development, LLCINDUSTRY	13	Sep 25, 2026